VTVan Du Thuong Tran

Van Du Thuong Tran

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Van Du Thuong Tran has a total of 216 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • FOCUS +: Enhancing Sustained Attention Through Comparative Evaluation of Digital and Physical Interventions

    by Trang Nguyen, Mckenna Kirk, Giang Ho, Thuy Duong Ta, Du Tran, Chi Thanh Vi

  • Open Access

    Manipulation of regulators of morphogenesis is not sufficient to render a Candida albicans colonizer strain pathogenic

    by Ricardo Fróis-Martins, Sarah Mertens, Van Du T. Tran, Corinne Maufrais, Christophe D'ENfert, Dominique Sanglard, Salomé LeibundGut-Landmann

    As a member of the microbiome, Candida albicans colonizes the oral cavity and other mucosal surfaces of the human body. While commensalism is tightly controlled by the host immune system, the fungal determinants enabling the fungus to colonize the host mucosa without causing tissue damage and inflammation remain less clear. In search of genetic determinants that may underlie the commensal lifestyle of the low-damage-inducing C. albicans isolate 101, we identified a small sequence duplication in one allele of the Brg1 hyphal morphogenesis regulator gene, resulting in a truncated loss-of-function allele ( BRG1 TRUNC ). Replacing BRG1 TRUNC by the full-length allele ( BRG1 FL ) resulted in a modest increase in filamentation but did not alter the phenotype of the fungus in the oral mucosa of experimentally colonized mice. Analysis of a spontaneous hyperfilamentous variant of the BRG1 FL / BRG1 FL derivative of C. albicans strain 101 identified a Glu-to-Lys change at position 1541 in the Cyr1 adenylate cyclase ( CYR1 E1541K ). While the CYR1 E1541K mutation led to greatly increased filamentation, expression of hyphae-associated genes, and host cell damage when tested in vitro , it was insufficient to render C. albicans strain 101 more pathogenic in the oral mucosa in vivo , irrespective of the BRG1 status. Together, this highlights that the low-damage-inducing nature of strain 101 cannot be overcome by manipulating BRG1 and CYR1 , two genes with known roles in C. albicans virulence. IMPORTANCE: During homeostasis, the fungus Candida albicans establishes mutualistic interactions with its human host. It can, however, also adopt a pathogenic state and cause infections with diverse clinical manifestations that pose a significant challenge for diagnosis and therapy. Understanding the fungal determinants that underlie C. albicans colonization under steady-state conditions may thus provide new avenues for modulating the fungus-host interaction in candidiasis patients to restore homeostasis. Here, we report gene variants in key regulators of C. albicans morphogenesis and virulence that distinguish strains with distinct capacity to drive inflammation and cause disease. Gene-exchange mutants provided evidence for the impact of a BRG1 loss-of-function allele and a CYR1 gain-of-function mutation toward in vitro biomarkers of fungal pathogenicity. However, in vivo in an experimental model of C. albicans oral colonization, none of these gene variants individually or in combination was sufficient to change the pathogenic state of the fungus. These findings indicate that C. albicans mucosal colonization is regulated by a complex gene network rather than by single genetic determinants.

  • Open Access

    Genome-guided manipulation of regulators of morphogenesis in a C. albicans strain with low virulence is not sufficient to trigger a high-virulence phenotype

    by Ricardo Frois-Martins, Sarah Mertens, Van Du Thuong Tran, Corinne Maufrais, Christophe D'Enfert, Dominique Sanglard, Salome LeibundGut-Landmann

    As a member of the microbiome, C. albicans colonizes the oral cavity and other mucosal surfaces of the human body. While commensalism is tightly controlled by the host immune system, the fungal determinants enabling the fungus to colonize the host mucosa without causing tissue damage and inflammation remain less clear. In search of genetic determinants that may underly the commensal lifestyle of the low-virulent C. albicans isolate 101, we identified a small sequence duplication in one of the BRG1 allele resulting in a truncated loss-of-function allele ( BRG1 TRUNC ). Replacing BRG1 TRUNC by the full-length allele ( BRG1 FL ) resulted in a modest increase in filamentation, but did not alter the phenotype of the fungus in the oral mucosa of experimentally colonized mice. Spontaneous outgrowth of highly virulent variants of the 101 strain with the BRG1 TRUNC alleles replaced by a full-length allele identified the Cyr1-cAMP-PKA signalling pathway as a modulator of fungal virulence. Although the Glu-to-Lys mutation in CYR1 ( CYR1 E1541K ), which converts Cyr1 into a hyperactive adenylate cyclase, greatly increased filamentation, the expression of hyphae-associated genes, and host cell damage when tested in vitro , it was insufficient to increase virulence of C. albicans strain 101 in the oral mucosa in vivo , irrespective of the BRG1 status. Together, this highlights that the low-virulent nature of strain 101 is firmly anchored and cannot be overcome by manipulating BRG1 and CYR1 , two genes with known roles in C. albicans virulence.


  • Open Access

    Microbiome variations in osteoarthritis reflect aging and metabolic factors, not the disease

    by Kajetana Bevc, Lukas Malfertheiner, Samuel Neuenschwander, Van Du Tran, Marco Pagni, Kateryna Pantiukh, Madis Jagura, Teemu Niiranen, Rob Knight, Veikko Salomaa, et al.

    The gut microbiome is crucial for human health. Its disruption has been linked to several chronic diseases, including joint disorders. The gut–joint axis has been implicated in the pathogenesis of osteoarthritis (OA), but conflicting findings and study limitations have led to uncertainty regarding the role of microbiota. We conducted a multi-cohort gut microbiota analysis in 1,395 OA patients from four European cohorts (Lifelines, EstMB, FINRISK 2002, TwinsUK), using stringent exclusion criteria and matched controls. When assessing microbial diversity, taxa, functional gene profiles, and gut permeability biomarkers, no significant differences were found between OA and controls. Although this does not exclude a causal contribution of the microbiota in the gut-joint-axis, its dysbiosis does not seem to be linked with OA disease progression. Instead, age and BMI appeared as the main contributing factors to microbiome changes. Microbiome studies in complex diseases often face challenges such as small sample sizes, batch effects, and limited ability to match appropriate controls, particularly in single-cohort designs. By combining data from multiple large cohorts, we were able to mitigate these limitations and provide a more robust assessment of microbiome association with OA. Our findings emphasize the need for rigorous study design in microbiome research and challenge the OA-gut dysbiosis hypothesis.

  • Top Cited Papers
    Open Access

    Immune digital twins for complex human pathologies: applications, limitations, and challenges

    by Anna Niarakis, Reinhard Laubenbacher, Gary An, Yaron Ilan, Jasmin Fisher, Åsmund Flobak, Kristin Reiche, María Rodríguez Martínez, Liesbet Geris, Luiz Ladeira, et al.

    Digital twins represent a key technology for precision health. Medical digital twins consist of computational models that represent the health state of individual patients over time, enabling optimal therapeutics and forecasting patient prognosis. Many health conditions involve the immune system, so it is crucial to include its key features when designing medical digital twins. The immune response is complex and varies across diseases and patients, and its modelling requires the collective expertise of the clinical, immunology, and computational modelling communities. This review outlines the initial progress on immune digital twins and the various initiatives to facilitate communication between interdisciplinary communities. We also outline the crucial aspects of an immune digital twin design and the prerequisites for its implementation in the clinic. We propose some initial use cases that could serve as “proof of concept” regarding the utility of immune digital technology, focusing on diseases with a very different immune response across spatial and temporal scales (minutes, days, months, years). Lastly, we discuss the use of digital twins in drug discovery and point out emerging challenges that the scientific community needs to collectively overcome to make immune digital twins a reality.


  • Open Access

    Profiling of insulin-resistant kidney models and human biopsies reveals common and cell-type-specific mechanisms underpinning Diabetic Kidney Disease

    by Abigail C. Lay, Van Du T. Tran, Viji Nair, Virginie Betin, Jennifer A. Hurcombe, Alexandra F. Barrington, Robert Jp Pope, Frédéric Burdet, Florence Mehl, Dmytro Kryvokhyzha, et al.

    Diabetic kidney disease (DKD) is the leading cause of end stage kidney failure worldwide, of which cellular insulin resistance is a major driver. Here, we study key human kidney cell types implicated in DKD (podocytes, glomerular endothelial, mesangial and proximal tubular cells) in insulin sensitive and resistant conditions, and perform simultaneous transcriptomics and proteomics for integrated analysis. Our data is further compared with bulk- and single-cell transcriptomic kidney biopsy data from early- and advanced-stage DKD patient cohorts. We identify several consistent changes (individual genes, proteins, and molecular pathways) occurring across all insulin-resistant kidney cell types, together with cell-line-specific changes occurring in response to insulin resistance, which are replicated in DKD biopsies. This study provides a rich data resource to direct future studies in elucidating underlying kidney signalling pathways and potential therapeutic targets in DKD.


  • ConsensusOPLS: Consensus OPLS for Multi-Block Data Fusion

    by Celine Bougel, Julien Boccard, Florence Mehl, Van Du T. Tran

  • Open Access

    A Federated Database for Obesity Research: An IMI-SOPHIA Study

    by Carl Delfin, Iulian Dragan, Dmitry Kuznetsov, Juan Fernandez Tajes, Femke Smit, Daniel E. Coral, Ali Farzaneh, André Haugg, Andreas Hungele, Anne Niknejad, et al.

    Obesity is considered by many as a lifestyle choice rather than a chronic progressive disease. The Innovative Medicines Initiative (IMI) SOPHIA (Stratification of Obesity Phenotypes to Optimize Future Obesity Therapy) project is part of a momentum shift aiming to provide better tools for the stratification of people with obesity according to disease risk and treatment response. One of the challenges to achieving these goals is that many clinical cohorts are siloed, limiting the potential of combined data for biomarker discovery. In SOPHIA, we have addressed this challenge by setting up a federated database building on open-source DataSHIELD technology. The database currently federates 16 cohorts that are accessible via a central gateway. The database is multi-modal, including research studies, clinical trials, and routine health data, and is accessed using the R statistical programming environment where statistical and machine learning analyses can be performed at a distance without any disclosure of patient-level data. We demonstrate the use of the database by providing a proof-of-concept analysis, performing a federated linear model of BMI and systolic blood pressure, pooling all data from 16 studies virtually without any analyst seeing individual patient-level data. This analysis provided similar point estimates compared to a meta-analysis of the 16 individual studies. Our approach provides a benchmark for reproducible, safe federated analyses across multiple study types provided by multiple stakeholders.


  • Open Access

    Usingin vivotranscriptomics and RNA enrichment to identify genes involved in virulence ofCandida glabrata

    by Sanne Schrevens, Eric Durandau, Van Du T. Tran, Dominique Sanglard

    Candida species are the most commonly isolated opportunistic fungal pathogens in humans. Candida albicans causes most of the diagnosed infections, closely followed by Candida glabrata. C. albicans is well studied, and many genes have been shown to be important for infection and colonization of the host. It is however less clear how C. glabrata infects the host. With the help of fungal RNA enrichment, we here investigated for the first time the transcriptomic profile of C. glabrata during urinary tract infection (UTI) in mice. In the UTI model, bladders and kidneys are major target organs and therefore fungal transcriptomes were addressed in these organs. Our results showed that, next to adhesins and proteases, nitrogen metabolism and regulation play a vital role during C. glabrata UTI. Genes involved in nitrogen metabolism were upregulated and among them we show that DUR1,2 (urea amidolyase) and GAP1 (amino acid permease) were important for virulence. Furthermore, we confirmed the importance of the glyoxylate cycle in the host and identified MLS1 (malate synthase) as an important gene necessary for C. glabrata virulence. In conclusion, our study shows with the support of in vivo transcriptomics how C. glabrata adapts to host conditions.


  • Open Access

    Candida albicans commensalism in the oral mucosa is favoured by limited virulence and metabolic adaptation

    by Christina Lemberg, Kontxi Martinez de San Vicente, Ricardo Fróis-Martins, Simon Altmeier, Van Du T. Tran, Sarah Mertens, Sara Amorim-Vaz, Laxmi Shanker Rai, Christophe D’enfert, Marco Pagni, et al.

    As part of the human microbiota, the fungusCandida albicanscolonizes the oral cavity and other mucosal surfaces of the human body. Commensalism is tightly controlled by complex interactions of the fungus and the host to preclude fungal elimination but also fungal overgrowth and invasion, which can result in disease. As such, defects in antifungal T cell immunity render individuals susceptible to oral thrush due to interrupted immunosurveillance of the oral mucosa. The factors that promote commensalism and ensure persistence ofC.albicansin a fully immunocompetent host remain less clear. Using an experimental model ofC.albicansoral colonization in mice we explored fungal determinants of commensalism in the oral cavity. Transcript profiling of the oral isolate 101 in the murine tongue tissue revealed a characteristic metabolic profile tailored to the nutrient poor conditions in the stratum corneum of the epithelium where the fungus resides. Metabolic adaptation of isolate 101 was also reflected in enhanced nutrient acquisition when grown on oral mucosa substrates. Persistent colonization of the oral mucosa byC.albicansalso correlated inversely with the capacity of the fungus to induce epithelial cell damage and to elicit an inflammatory response. Here we show that these immune evasive properties of isolate 101 are explained by a strong attenuation of a number of virulence genes, including those linked to filamentation. De-repression of the hyphal program by deletion or conditional repression ofNRG1abolished the commensal behaviour of isolate 101, thereby establishing a central role of this factor in the commensal lifestyle ofC.albicansin the oral niche of the host.